Canadian drugmaker Labopharm has been boosted by the news that manufacturing problems holding up approval of its novel antidepressant product, …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

